The Evolving Field of Treatment ModalitiesVideo Categories: 2018 AONN Midyear, Immunotherapy, and Video Library
Dr Morganna Freeman considers the future application of treatment modalities and how they might be combined for optimal results.
Dixie-Lee Esseltine, MD and George Mulligan, PhD shed light on the challenges that payers and practice managers will face as more oncolytics come into the market.
Drs. Geoffrey Oxnard and Lauren Ritterhouse deliberate on ways reimbursement issues are impacting clinical practice, particularly CMS’s “14-Day Rule.”